Tandem Diabetes Care Inc (TNDM): Next-Year EPS Estimate 119.06%
As of 2026-10-16, Tandem Diabetes Care Inc (TNDM) has a next-year EPS growth estimate of 119.06%. Featured in our EPS revision report on 2026-07-20.
On 2026-10-13, analyst consensus for TNDM's next-year EPS growth shifted from 119.09% to 119.06% — a negative change of 0.03 percentage points. The revised estimate has been sustained across 4 subsequent trading sessions. Current-year growth is projected at 53.99%.
What's Driving This
TNDM shares have risen primarily on a sharp upward revision in next-year EPS growth estimates, which moved from 113.09% to 119.85% on July 16,
Generated 2026-09-21 from news as of 2026-09-21
Current Snapshot
- Sector
- Healthcare
- Industry
- Medical Devices
- EPS growth next year
- 119.06%
- EPS growth this year
- 53.99%
- EPS next quarter (est)
- -$0.25
- Last price
- $16.24
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-10-16 | 119.06% | 53.99% | -$0.25 | $16.24 |
| 2026-10-15 | 119.06% | 53.99% | -$0.25 | $16.52 |
| 2026-10-14 | 119.06% | 53.99% | -$0.25 | $16.01 |
| 2026-10-13 | 119.06% | 53.99% | -$0.25 | $16.65 |
| 2026-10-12 | 119.09% | 53.98% | -$0.25 | $16.45 |
| 2026-10-11 | 119.09% | 53.98% | -$0.25 | $16.11 |
| 2026-10-10 | 119.09% | 53.98% | -$0.25 | $16.11 |
| 2026-10-09 | 119.09% | 53.98% | -$0.25 | $16.11 |
| 2026-10-08 | 119.09% | 53.98% | -$0.25 | $15.68 |
| 2026-10-07 | 119.09% | 53.98% | -$0.25 | $15.84 |
| 2026-10-06 | 120.44% | 53.75% | -$0.25 | $16.16 |
| 2026-10-05 | 120.44% | 53.75% | -$0.25 | $16.52 |
| 2026-10-04 | 120.44% | 53.75% | -$0.25 | $16.50 |
| 2026-10-03 | 120.44% | 53.75% | -$0.25 | $16.50 |
| 2026-10-02 | 120.44% | 53.75% | -$0.25 | $16.50 |
| 2026-10-01 | 120.45% | 53.73% | -$0.25 | $16.50 |
| 2026-09-30 | 119.97% | 53.60% | -$0.25 | $16.31 |
| 2026-09-29 | 120.67% | 53.89% | -$0.24 | $16.57 |
| 2026-09-28 | 120.67% | 53.89% | -$0.24 | $16.42 |
| 2026-09-27 | 120.67% | 53.89% | -$0.24 | $15.72 |
| 2026-09-25 | 120.67% | 53.89% | -$0.24 | $15.72 |
| 2026-09-24 | 120.67% | 53.89% | -$0.24 | $15.22 |
| 2026-09-23 | 121.15% | 54.02% | -$0.24 | $16.38 |
| 2026-09-22 | 121.15% | 54.02% | -$0.24 | $17.50 |
| 2026-09-21 | 121.15% | 54.02% | -$0.24 | $17.62 |
| 2026-09-20 | 121.15% | 54.02% | -$0.24 | $16.87 |
| 2026-09-18 | 121.15% | 54.02% | -$0.24 | $16.87 |
| 2026-09-17 | 121.15% | 54.02% | -$0.24 | $17.23 |
| 2026-09-16 | 121.15% | 54.02% | -$0.24 | $17.53 |
| 2026-09-15 | 121.15% | 54.02% | -$0.24 | $16.28 |
Reports Featuring TNDM
Recent News
- Tandem Diabetes Care to Announce Third Quarter 2026 Financial Results on November 5, 2026Business Wire
- Tandem Diabetes Care, Inc. Q2 2026 Earnings Call SummaryMoby
- Tandem to file tubeless insulin pump with FDA this quarterMedTech Dive
- Tandem Diabetes Care, Inc. Q1 2026 Earnings Call SummaryMoby
- Tandem Diabetes Care Announces First Quarter 2026 Financial ResultsBusiness Wire
Screen Performance
Aggregate stats across all 2082 tickers our top-EPS-revision screen has flagged over the past 198 days.
- Median return since detection
- -3.0%
- % of tickers in the green
- 43%
- Median return on winners
- +21.5%
- Large revisions captured
- 1886
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Also Tracked by Our Screen
Frequently Asked Questions
What is Tandem Diabetes Care Inc's next-year EPS growth estimate?▾
As of 2026-10-16, Tandem Diabetes Care Inc (TNDM) has a next-year EPS growth estimate of 119.06%, based on analyst consensus.
When was the latest EPS estimate revision for TNDM?▾
The most recent revision occurred on 2026-10-13, when analysts adjusted the next-year EPS growth estimate from 119.09% to 119.06%.
What sector and industry does Tandem Diabetes Care Inc belong to?▾
Tandem Diabetes Care Inc operates in the Healthcare sector, specifically the Medical Devices industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. TNDM appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Tandem Diabetes Care Inc (TNDM) appears here because it was detected by our daily top-EPS-revision-performer screen.